Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial.
Yingling ZuRuirui GuiZhen LiJuan WangYanli ZhangFengkuan YuHuifang ZhaoXinrong ZhanZhongliang WangPengtao XingXianjing WangHuili WangYongping SongJian ZhouPublished in: Blood cancer journal (2023)